GHP NewsLatest Science Literature update ViVa week 38-2026 1. Three doses help—but immunosuppressed patients remain a COVID-19 high-risk group Summary: In a systematic review and random-effects meta-analysis, Stadler and colleagues searched PubMed, Scopus, and Embase through... 23 September, 202612 min read